Marx S J, Jones G, Weinstein R S, Chrousos G P, Renquist D M
Mineral Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892.
J Clin Endocrinol Metab. 1989 Dec;69(6):1282-90. doi: 10.1210/jcem-69-6-1282.
We tested for differences in aspects of mineral metabolism during the administration of diets with only vitamin D3 or only vitamin D2 in four nonhuman anthropoid primate species [two catarrhini, Macaca fascicularis (crab-eating macaque) and Macaca mulatta (rhesus macaque), and two platyrrhini, Saimiri sciureus (squirrel monkey) and Aotus vociferans (night monkey)]. All four species maintained approximately 2- to 3-fold higher serum 25-hydroxyvitamin D (25OHD) level while receiving vitamin D3 than while receiving similar amounts of vitamin D2. Serum 25OHD in M. mulatta receiving the standard primate dietary supplement of vitamin D3 was high enough (360 +/- 60 vs. 70 +/- 25 nM in vitamin D-supplemented humans; P less than 0.0001) to suggest that this widely used level of vitamin D3 supplementation is excessive for some M. mulatta. Serum 24,25-dihydroxyvitamin D [24,25-(OH)2D] in A. vociferans was uniquely high [P less than 0.01; species mean, 19 +/- 5, 95 +/- 12, and 27 +/- 5 nM in groups receiving diets with 1.5 IU vitamin D3/g, 6.6 IU vitamin D3/g, and 15 IU vitamin D2/g, respectively; mean 24,25-(OH)2D from the other three species pooled across three diets was 7 +/- 5 nM]. We confirmed relative resistance to 1,25-(OH)2D in S. sciureus, manifested by osteomalacia and moderately high serum 1,25-(OH)2D. Serum 1,25-(OH)2D in S. sciureus increased 4-fold (P less than 0.05) when the precursor in serum was changed from 250HD3 to 250HD2, suggesting that this species shows more severe resistance to 1,25-(OH)2D2 than to 1,25-(OH)2D3. In conclusion, we found many differences in vitamin D metabolism among four nonhuman anthropoid primate species. The striking feature in A. vociferans (high, 24,25-(OH)2D without high 25OHD in serum independent of whether diet contained only vitamin D3 or only vitamin D2) should allow determination of whether 24,25-(OH)2D functions as a unique agonist or an inactive metabolite in this species.
我们在四种非人灵长类动物中测试了仅给予维生素D3或仅给予维生素D2饮食时矿物质代谢方面的差异[两种狭鼻猴,食蟹猕猴(Macaca fascicularis)和恒河猴(Macaca mulatta),以及两种阔鼻猴,松鼠猴(Saimiri sciureus)和夜猴(Aotus vociferans)]。所有这四个物种在接受维生素D3时血清25-羟基维生素D(25OHD)水平比接受等量维生素D2时维持在大约高2至3倍。接受标准灵长类动物维生素D3膳食补充剂的恒河猴血清25OHD足够高(360±60对比补充维生素D的人类中的70±25 nM;P<0.0001),这表明这种广泛使用的维生素D3补充水平对一些恒河猴来说过高。夜猴血清24,25-二羟基维生素D[24,25-(OH)2D]独特地高[P<0.01;在分别接受含1.5 IU维生素D3/g、6.6 IU维生素D3/g和15 IU维生素D2/g饮食的组中,物种平均值分别为19±5、95±12和27±5 nM;来自其他三个物种在三种饮食中的合并平均24,25-(OH)2D为7±5 nM]。我们证实松鼠猴对1,25-(OH)2D有相对抗性,表现为骨软化症和中等程度高的血清1,25-(OH)2D。当血清中的前体从250HD3变为250HD2时,松鼠猴血清1,25-(OH)2D增加了4倍(P<0.05),这表明该物种对1,25-(OH)2D2的抗性比对1,25-(OH)2D3更严重。总之,我们在四种非人灵长类动物物种中发现了维生素D代谢的许多差异。夜猴的显著特征(血清中24,25-(OH)2D高,无论饮食仅含维生素D3还是仅含维生素D2时25OHD都不高)应有助于确定24,25-(OH)2D在该物种中是作为独特的激动剂还是无活性代谢物发挥作用。